By Matthew Bultman ( February 6, 2018, 9:09 PM EST) -- The Federal Circuit said Tuesday that Actelion Pharmaceuticals Ltd. was not entitled to a patent term adjustment that would have added several days to the life of a patent beyond an adjustment the U.S. Patent and Trademark Office granted, upholding a lower court's decision....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.